Costs of integrated mass drug administration for neglected tropical diseases in Haiti.

Authors:
Address: The George Washington University School of Public Health and Health Services, Washington, District of Columbia 20037, USA. sphasg@gwumc.edu
Journal:

Publication:

abstract

We conducted a cost analysis of Haiti's Ministry of Public Health and Population neglected tropical disease program, Projet des Maladies Tropicales Negligées and collected data for 9 of 55 communes participating in the May 2008-April 2009 mass drug administration (MDA). The Projet des Maladies Tropicales Negligées Program partnered with IMA World Health and Hôpital Ste. Croix to implement MDA for treatment of lymphatic filariasis and soil-transmitted helminthiasis by using once a year treatment with albendazole and diethylcarbamazine in a population of approximately 8 million persons. Methods included analyzing partner financial records and conducting retrospective surveys of personnel. In the nine communes, 633,261 persons were treated at a cost of U.S. $0.64 per person, which included the cost of donated drugs, and at a cost of U.S. $0.42 per person treated, when excluding donated drug Costs. The MDA for lymphatic filariasis in Haiti began in 2000, with the treatment of 105,750 persons at a cost per person of U.S. $2.23. The decrease in cost per person treated is the result of cumulative implementation experience and economies of scale.

Related Articles
National mass drug administration costs for lymphatic filariasis elimination.
PLoS Negl Trop Dis. 2007
National mass drug administration costs for lymphatic filariasis elimination.
Goldman AS, Guisinger VH, Aikins M, Amarillo ML, Belizario VY, Garshong B, Gyapong J, Kabali C, Kamal HA, Kanjilal S, et al. PLoS Negl Trop Dis. 2007 Oct 31; 1(1):e67. Epub 2007 Oct 31.
Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
Am J Trop Med Hyg. 2003
Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
McLaughlin SI, Radday J, Michel MC, Addiss DG, Beach MJ, Lammie PJ, Lammie J, Rheingans R, Lafontant J. Am J Trop Med Hyg. 2003 May; 68(5):568-73.
The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
Am J Trop Med Hyg. 2005
The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
de Rochars MB, Kanjilal S, Direny AN, Radday J, Lafontant JG, Mathieu E, Rheingans RD, Haddix AC, Streit TG, Beach MJ, et al. Am J Trop Med Hyg. 2005 Nov; 73(5):888-94.
Review Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
Trop Med Int Health. 2006
Review Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
de Kraker ME, Stolk WA, van Oortmarssen GJ, Habbema JD. Trop Med Int Health. 2006 May; 11(5):718-28.
Review Chemistry and pharmacology of neglected helminthic diseases.
Curr Med Chem. 2011
Review Chemistry and pharmacology of neglected helminthic diseases.
Müllner A, Helfer A, Kotlyar D, Oswald J, Efferth T. Curr Med Chem. 2011; 18(5):767-89.
Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: identifying best practices to roll out programs at national scale.
Am J Trop Med Hyg. 2012
Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: identifying best practices to roll out programs at national scale.
Hanson C, Weaver A, Zoerhoff KL, Kabore A, Linehan M, Doherty A, Engels D, Savioli L, Ottesen EA. Am J Trop Med Hyg. 2012 Mar; 86(3):508-13.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.